Antibody Therapeutics for Life

Notices

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to present at the 2nd Korean Immuno-Oncology Symposium 2019 March 8th,
  • Written by Admin
  • Written date 2019-02-07 09:30:17
  • Inquire 4994

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to present at the 2nd Korean Immuno-Oncology Symposium 2019 March 8th.

 (http://www.cancer.or.kr/abstract/2019_kios/sche.html).

List





Prev PharmAbcine, a clinical stage immune-oncology company, today announced that Dr....
Next PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. ...